The microbiome and critical illness

The Lancet Respiratory Medicine

Volumn 4, Issue 1, 2016, Pages 59-72

  Dickson, Robert P ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM CULTURE; CHRONIC LUNG DISEASE; CLINICAL INTERVENTION; CLINICAL RESEARCH; CRITICAL ILLNESS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE MODEL; DISEASE PREDISPOSITION; ECOSYSTEM; HUMAN; INTENSIVE CARE; LUNG ALVEOLUS; MICROBIOLOGY; MICROBIOME; MULTIPLE ORGAN FAILURE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; REVIEW; SEPSIS; THERAPY; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; ASTHMA; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; INTESTINE FLORA; LUNG; MICROFLORA; PNEUMONIA;

ANIMALS; ASTHMA; BRONCHIECTASIS; CRITICAL ILLNESS; CYSTIC FIBROSIS; DISEASE PROGRESSION; GASTROINTESTINAL MICROBIOME; HUMANS; LUNG; MICROBIOTA; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS;

EID: 84952984042     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(15)00427-0     Document Type: Review

References (164)

1. Adhikari NK, Fowler RA, Bhagwanjee S, Rubenfeld GD Critical care and the global burden of critical illness in adults. Lancet 2010, 376:1339-1346.
2. Dickson RP, Erb-Downward JR, Huffnagle GB The role of the bacterial microbiome in lung disease. Expert Rev Respir Med 2013, 7:245-257.
3. Kuczynski J, Lauber CL, Walters WA, et al. Experimental and analytical tools for studying the human microbiome. Nat Rev Genet 2012, 13:47-58.
4. Johanson WG, Pierce AK, Sanford JP Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med 1969, 281:1137-1140.
5. Baas Becking LGM Geobiologie, of Inleiding Tot de Milieukunde: Met Literatuurlijst en Ind 1934, Van Stockum, The Hague.
6. David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014, 505:559-563.
7. Bahrani-Mougeot FK, Paster BJ, Coleman S, et al. Molecular analysis of oral and respiratory bacterial species associated with ventilator-associated pneumonia. J Clin Microbiol 2007, 45:1588-1593.
8. Björnsson ES, Urbanavicius V, Eliasson B, Attvall S, Smith U, Abrahamsson H Effects of hyperglycemia on interdigestive gastrointestinal motility in humans. Scand J Gastroenterol 1994, 29:1096-1104.
9. Lowman RM The potassium depletion states and postoperative ileus. The role of the potassium ion. Radiology 1971, 98:691-694.
10. O'Boyle CJ, MacFie J, Mitchell CJ, Johnstone D, Sagar PM, Sedman PC Microbiology of bacterial translocation in humans. Gut 1998, 42:29-35.
11. MacFie J, Reddy BS, Gatt M, Jain PK, Sowdi R, Mitchell CJ Bacterial translocation studied in 927 patients over 13 years. Br J Surg 2006, 93:87-93.
12. Deitch EA Gut-origin sepsis: evolution of a concept. Surgeon 2012, 10:350-356.
13. Winter SE, Winter MG, Xavier MN, et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 2013, 339:708-711.
14. Lupp C, Robertson ML, Wickham ME, et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. cell Host Microbe 2007, 2:204.
15. Honda K, Littman DR The microbiome in infectious disease and inflammation. Annu Rev Immunol 2012, 30:759-795.
16. Grootjans J, Lenaerts K, Derikx JP, et al. Human intestinal ischemia-reperfusion-induced inflammation characterized: experiences from a new translational model. Am J Pathol 2010, 176:2283-2291.
17. de Vree JM, Romijn JA, Mok KS, et al. Lack of enteral nutrition during critical illness is associated with profound decrements in biliary lipid concentrations. Am J Clin Nutr 1999, 70:70-77.
18. Begley M, Gahan CG, Hill C The interaction between bacteria and bile. FEMS Microbiol Rev 2005, 29:625-651.
19. Zaborina O, Lepine F, Xiao G, et al. Dynorphin activates quorum sensing quinolone signaling in Pseudomonas aeruginosa. PLoS Pathog 2007, 3:e35.
20. Zaborin A, Smith D, Garfield K, et al. Membership and behavior of ultra-low-diversity pathogen communities present in the gut of humans during prolonged critical illness. MBio 2014, 5:e01361-e01414.
21. Dive A, Foret F, Jamart J, Bulpa P, Installé E Effect of dopamine on gastrointestinal motility during critical illness. Intensive Care Med 2000, 26:901-907.
22. Alverdy J, Holbrook C, Rocha F, et al. Gut-derived sepsis occurs when the right pathogen with the right virulence genes meets the right host: evidence for in vivo virulence expression in Pseudomonas aeruginosa. Ann Surg 2000, 232:480-489.
23. Meduri GU, Kanangat S, Stefan J, Tolley E, Schaberg D Cytokines IL-1beta, IL-6, and TNF-alpha enhance in vitro growth of bacteria. Am J Respir Crit Care Med 1999, 160:961-967.
24. Kanangat S, Meduri GU, Tolley EA, et al. Effects of cytokines and endotoxin on the intracellular growth of bacteria. Infect Immun 1999, 67:2834-2840.
25. Lu Q, Xu DZ, Sharpe S, et al. The anatomic sites of disruption of the mucus layer directly correlate with areas of trauma/hemorrhagic shock-induced gut injury. J Trauma 2011, 70:630-635.
26. Rupani B, Caputo FJ, Watkins AC, et al. Relationship between disruption of the unstirred mucus layer and intestinal restitution in loss of gut barrier function after trauma hemorrhagic shock. Surgery 2007, 141:481-489.
27. Katayama M, Xu D, Specian RD, Deitch EA Role of bacterial adherence and the mucus barrier on bacterial translocation: effects of protein malnutrition and endotoxin in rats. Ann Surg 1997, 225:317-326.
28. Morehouse JL, Specian RD, Stewart JJ, Berg RD Translocation of indigenous bacteria from the gastrointestinal tract of mice after oral ricinoleic acid treatment. Gastroenterology 1986, 91:673-682.
29. Albenberg L, Esipova TV, Judge CP, et al. Correlation between intraluminal oxygen gradient and radial partitioning of intestinal microbiota. Gastroenterology 2014, 147:1055. 63.e8.
30. Meyer-Hoffert U, Hornef MW, Henriques-Normark B, et al. Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut 2008, 57:764-771.
31. Coutinho HB, Robalinho TI, Coutinho VB, et al. Intra-abdominal sepsis: an immunocytochemical study of the small intestine mucosa. J Clin Pathol 1997, 50:294-298.
32. Book M, Chen Q, Lehmann LE, et al. Inducibility of the endogenous antibiotic peptide beta-defensin 2 is impaired in patients with severe sepsis. Crit Care 2007, 11:R19.
33. Teltschik Z, Wiest R, Beisner J, et al. Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense. Hepatology 2012, 55:1154-1163.
34. Salzman NH, Hung K, Haribhai D, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010, 11:76-83.
35. Peterson DA, McNulty NP, Guruge JL, Gordon JI IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe 2007, 2:328-339.
36. Moore JG, Datz FL, Christian PE, Greenberg E, Alazraki N Effect of body posture on radionuclide measurements of gastric emptying. Dig Dis Sci 1988, 33:1592-1595.
37. Cordova-Fraga T, Sosa M, Wiechers C, et al. Effects of anatomical position on esophageal transit time: a biomagnetic diagnostic technique. World J Gastroenterol 2008, 14:5707-5711.
38. Lombardo L, Foti M, Ruggia O, Chiecchio A Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol 2010, 8:504-508.
39. Du Moulin GC, Hedley-Whyte J, Paterson DG, Lisbon A Aspiration of gastric bacteria in antacid-treated patients: a frequent cause of postoperative colonisation of the airway. Lancet 1982, 319:242-245.
40. Hadfield RJ, Sinclair DG, Houldsworth PE, Evans TW Effects of enteral and parenteral nutrition on gut mucosal permeability in the critically ill. Am J Respir Crit Care Med 1995, 152:1545-1548.
41. Schneider SM, Le Gall P, Girard-Pipau F, et al. Total artificial nutrition is associated with major changes in the fecal flora. Eur J Nutr 2000, 39:248-255.
42. Alverdy JC, Aoys E, Moss GS Total parenteral nutrition promotes bacterial translocation from the gut. Surgery 1988, 104:185-190.
43. Alverdy J, Chi HS, Sheldon GF The effect of parenteral nutrition on gastrointestinal immunity. The importance of enteral stimulation. Ann Surg 1985, 202:681-684.
44. Benus RF, Harmsen HJ, Welling GW, et al. Impact of digestive and oropharyngeal decontamination on the intestinal microbiota in ICU patients. Intensive Care Med 2010, 36:1394-1402.
45. Metheny NA, Clouse RE, Chang YH, Stewart BJ, Oliver DA, Kollef MH Tracheobronchial aspiration of gastric contents in critically ill tube-fed patients: frequency, outcomes, and risk factors. Crit Care Med 2006, 34:1007-1015.
46. Sekizawa K, Ujiie Y, Itabashi S, Sasaki H, Takishima T Lack of cough reflex in aspiration pneumonia. Lancet 1990, 335:1228-1229.
47. Nakagawa NK, Franchini ML, Driusso P, de Oliveira LR, Saldiva PH, Lorenzi-Filho G Mucociliary clearance is impaired in acutely ill patients. Chest 2005, 128:2772-2777.
48. Worlitzsch D, Tarran R, Ulrich M, et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 2002, 109:317-325.
49. Schmidt A, Belaaouaj A, Bissinger R, et al. Neutrophil elastase-mediated increase in airway temperature during inflammation. J Cyst Fibros 2014, 13:623-631.
50. Dickson RP, Erb-Downward JR, Prescott HC, et al. Intraalveolar catecholamines and the human lung microbiome. Am J Respir Crit Care Med 2015, 192:257-259.
51. Freestone PP, Hirst RA, Sandrini SM, et al. Pseudomonas aeruginosa-catecholamine inotrope interactions: a contributory factor in the development of ventilator-associated pneumonia?. Chest 2012, 142:1200-1210.
52. Finlay BB, McFadden G Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. cell 2006, 124:767-782.
53. Wedzicha JA, Seemungal TA COPD exacerbations: defining their cause and prevention. Lancet 2007, 370:786-796.
54. Lee WL, Downey GP Neutrophil activation and acute lung injury. Curr Opin Crit Care 2001, 7:1-7.
55. Günther A, Siebert C, Schmidt R, et al. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 1996, 153:176-184.
56. Poroyko V, Meng F, Meliton A, et al. Alterations of lung microbiota in a mouse model of LPS-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2015, 309:L76-L83.
57. Wu H, Kuzmenko A, Wan S, et al. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest 2003, 111:1589-1602.
58. Torres A, Serra-Batlles J, Ros E, et al. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med 1992, 116:540-543.
59. Li Bassi G, Zanella A, Cressoni M, Stylianou M, Kolobow T Following tracheal intubation, mucus flow is reversed in the semirecumbent position: possible role in the pathogenesis of ventilator-associated pneumonia. Crit Care Med 2008, 36:518-525.
60. Slutsky AS, Ranieri VM Ventilator-induced lung injury. N Engl J Med 2013, 369:2126-2136.
61. Muscedere J, Rewa O, McKechnie K, Jiang X, Laporta D, Heyland DK Subglottic secretion drainage for the prevention of ventilator-associated pneumonia: a systematic review and meta-analysis. Crit Care Med 2011, 39:1985-1991.
62. Flanagan JL, Brodie EL, Weng L, et al. Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa. J Clin Microbiol 2007, 45:1954-1962.
63. Simon GL, Gorbach SL Intestinal flora in health and disease. Gastroenterology 1984, 86:174-193.
64. Marshall JC, Christou NV, Meakins JL The gastrointestinal tract. The "undrained abscess" of multiple organ failure. Ann Surg 1993, 218:111-119.
65. Knoop KA, McDonald KG, Kulkarni DH, Newberry RD Antibiotics promote inflammation through the translocation of native commensal colonic bacteria. Gut 2015, published online June 4. 10.1136/gutjnl-2014-309059.
66. Dethlefsen L, Relman DA Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 2011, 108(suppl 1):4554-4561.
67. Marshall JC, Christou NV, Horn R, Meakins JL The microbiology of multiple organ failure. The proximal gastrointestinal tract as an occult reservoir of pathogens. Arch Surg 1988, 123:309-315.
68. de la Cal MA, Rommes JH, van Saene HK, Silvestri L, Zandstra DF Selective digestive decontamination and bacterial resistance. Lancet Infect Dis 2013, 13:738.
69. Shimizu K, Ogura H, Hamasaki T, et al. Altered gut flora are associated with septic complications and death in critically ill patients with systemic inflammatory response syndrome. Dig Dis Sci 2011, 56:1171-1177.
70. Madan JC, Salari RC, Saxena D, et al. Gut microbial colonisation in premature neonates predicts neonatal sepsis. Arch Dis Child Fetal Neonatal Ed 2012, 97:F456-F462.
71. Shimizu K, Ogura H, Goto M, et al. Altered gut flora and environment in patients with severe SIRS. J Trauma 2006, 60:126-133.
72. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 1988, 148:2642-2645.
73. Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180. the MetaHIT Consortium.
74. Blaser MJ The microbiome revolution. J Clin Invest 2014, 124:4162-4165.
75. Donohoe DR, Garge N, Zhang X, et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 2011, 13:517-526.
76. Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013, 504:446-450.
77. Dickson RP, Erb-Downward JR, Freeman CM, et al. Spatial Variation in the healthy human lung microbiome and the adapted island model of lung biogeography. Ann Am Thorac Soc 2015, 12:821-830.
78. Gleeson K, Eggli DF, Maxwell SL Quantitative aspiration during sleep in normal subjects. Chest 1997, 111:1266-1272.
79. Segal LN, Alekseyenko AV, Clemente JC, et al. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome 2013, 1:19.
80. Bassis CM, Erb-Downward JR, Dickson RP, et al. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. MBio 2015, 6:e00037.
81. Munro CL, Grap MJ Oral health and care in the intensive care unit: state of the science. Am J Crit Care 2004, 13:25-33.
82. Bousbia S, Papazian L, Saux P, et al. Repertoire of intensive care unit pneumonia microbiota. PLoS One 2012, 7:e32486.
83. Lu W, Yu J, Ai Q, Liu D, Song C, Li L Increased constituent ratios of Klebsiella sp., Acinetobacter sp., and Streptococcus sp. and a decrease in microflora diversity may be indicators of ventilator-associated pneumonia: a prospective study in the respiratory tracts of neonates. PLoS One 2014, 9:e87504.
84. May AK, Brady JS, Romano-Keeler J, et al. A pilot study of the noninvasive assessment of the lung microbiota as a potential tool for the early diagnosis of ventilator-associated pneumonia. Chest 2015, 147:1494-1502.
85. Senator H Über einen Fall von Hydrothionämie und über Selbstinfection durch abnorme Verdauungsvorgänge. Berliner Klinische Wochenschrift 1868, 254-256. A Hirschwald, Berlin. L. Waldenberg (Ed.).
86. Chain E, Florey HW, Gardner AD, et al. Penicillin as a chemotherapeutic agent. Lancet 1940, 236:226-228.
87. Fine J, Frank H, Schweinburg F, Jacob S, Gordon T The bacterial factor in traumatic shock. Ann N Y Acad Sci 1952, 55:429-445.
88. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE Acute respiratory distress in adults. Lancet 1967, 2:319-323.
89. Cuevas P, De la Maza LM, Gilbert J, Fine J The lung lesion in four different types of shock in rabbits. Arch Surg 1972, 104:319-322.
90. Souza DG, Vieira AT, Soares AC, et al. The essential role of the intestinal microbiota in facilitating acute inflammatory responses. J Immunol 2004, 173:4137-4146.
91. Silvestri L, van Saene HK, Zandstra DF, Marshall JC, Gregori D, Gullo A Impact of selective decontamination of the digestive tract on multiple organ dysfunction syndrome: systematic review of randomized controlled trials. Crit Care Med 2010, 38:1370-1376.
92. Liberati A, D'Amico R, Pifferi S, Torri V, Brazzi L, Parmelli E Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev 2009, 4. CD000022.
93. Zhang D, Chen G, Manwani D, et al. Neutrophil ageing is regulated by the microbiome. Nature 2015, 525:528-532.
94. Rush BF, Redan JA, Flanagan JJ, et al. Does the bacteremia observed in hemorrhagic shock have clinical significance? A study in germ-free animals. Ann Surg 1989, 210:342-345.
95. Unertl K, Ruckdeschel G, Selbmann HK, et al. Prevention of colonization and respiratory infections in long-term ventilated patients by local antimicrobial prophylaxis. Intensive Care Med 1987, 13:106-113.
96. Silvestri L, de la Cal MA, van Saene HK Selective decontamination of the digestive tract: the mechanism of action is control of gut overgrowth. Intensive Care Med 2012, 38:1738-1750.
97. Daneman N, Sarwar S, Fowler RA, Cuthbertson BH Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. Lancet Infect Dis 2013, 13:328-341. the SuDDICU Canadian Study Group.
98. Oostdijk EA, de Smet AM, Blok HE, et al. Ecological effects of selective decontamination on resistant gram-negative bacterial colonization. Am J Respir Crit Care Med 2010, 181:452-457.
99. Prescott HC, Dickson RP, Rogers MA, Langa KM, Iwashyna TJ Hospitalization type and subsequent severe sepsis. Am J Respir Crit Care Med 2015, 192:581-588.
100. Doig CJ, Sutherland LR, Sandham JD, Fick GH, Verhoef M, Meddings JB Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med 1998, 158:444-451.
101. Moore FA, Moore EE, Poggetti R, et al. Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. J Trauma 1991, 31:629-636.
102. Deitch EA, Xu D-Z, Lu Q Gut lymph hypothesis of early shock and trauma-induced multiple organ dysfunction syndrome: a new look at gut origin sepsis. J Organ Dysfunct 2006, 2:70-79.
103. Sedman PC, Macfie J, Sagar P, et al. The prevalence of gut translocation in humans. Gastroenterology 1994, 107:643-649.
104. Reino DC, Pisarenko V, Palange D, et al. Trauma hemorrhagic shock-induced lung injury involves a gut-lymph-induced TLR4 pathway in mice. PLoS One 2011, 6:e14829.
105. Alverdy JC, Laughlin RS, Wu L Influence of the critically ill state on host-pathogen interactions within the intestine: gut-derived sepsis redefined. Crit Care Med 2003, 31:598-607.
106. Schuijt TJ, van der Poll T, de Vos WM, Wiersinga WJ The intestinal microbiota and host immune interactions in the critically ill. Trends Microbiol 2013, 21:221-229.
107. Seely AJ, Christou NV Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems. Crit Care Med 2000, 28:2193-2200.
108. Suau A, Bonnet R, Sutren M, et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999, 65:4799-4807.
109. Bjarnason I, Williams P, Smethurst P, Peters TJ, Levi AJ Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut 1986, 27:1292-1297.
110. Alverdy J, Aoys E The effect of glucocorticoid administration on bacterial translocation. Evidence for an acquired mucosal immunodeficient state. Ann Surg 1991, 214:719-723.
111. Meng J, Yu H, Ma J, et al. Morphine induces bacterial translocation in mice by compromising intestinal barrier function in a TLR-dependent manner. PLoS One 2013, 8:e54040.
112. Venkataraman A, Bassis CM, Beck JM, et al. Application of a neutral community model to assess structuring of the human lung microbiome. MBio 2015, 6:e01163-e01215.
113. Dickson RP, Erb-Downward JR, Huffnagle GB Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis. Lancet Respir Med 2014, 2:238-246.
114. Bauer TT, Ewig S, Rodloff AC, Müller EE Acute respiratory distress syndrome and pneumonia: a comprehensive review of clinical data. Clin Infect Dis 2006, 43:748-756.
115. Chastre J, Trouillet JL, Vuagnat A, et al. Nosocomial pneumonia in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1998, 157:1165-1172.
116. Futier E, Constantin JM, Paugam-Burtz C, et al. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med 2013, 369:428-437. the IMPROVE study group.
117. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995, 108:1303-1314.
118. Freestone P Communication between bacteria and their hosts. Scientifica (Cairo) 2013, 2013:361073.
119. Sandrini S, Aldriwesh M, Alruways M, Freestone P Microbial endocrinology: host-bacteria communication within the gut microbiome. J Endocrinol 2015, 225:R21-R34.
120. Flierl MA, Rittirsch D, Nadeau BA, et al. Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 2007, 449:721-725.
121. Marks LR, Davidson BA, Knight PR, Hakansson AP Interkingdom signaling induces Streptococcus pneumoniae biofilm dispersion and transition from asymptomatic colonization to disease. MBio 2013, 4:e00438-e00513.
122. O'Donnell PM, Aviles H, Lyte M, Sonnenfeld G Enhancement of in vitro growth of pathogenic bacteria by norepinephrine: importance of inoculum density and role of transferrin. Appl Environ Microbiol 2006, 72:5097-5099.
123. Freestone PP, Haigh RD, Williams PH, Lyte M Stimulation of bacterial growth by heat-stable, norepinephrine-induced autoinducers. FEMS Microbiol Lett 1999, 172:53-60.
124. Kaza SK, McClean S, Callaghan M IL-8 released from human lung epithelial cells induced by cystic fibrosis pathogens Burkholderia cepacia complex affects the growth and intracellular survival of bacteria. Int J Med Microbiol 2011, 301:26-33.
125. Plotkin BJ, Roose RJ, Erikson Q, Viselli SM Effect of androgens and glucocorticoids on microbial growth and antimicrobial susceptibility. Curr Microbiol 2003, 47:514-520.
126. Dickson RP, Martinez FJ, Huffnagle GB The role of the microbiome in exacerbations of chronic lung diseases. Lancet 2014, 384:691-702.
127. Flume PA, Mogayzel PJ, Robinson KA, et al. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med 2009, 180:802-808. the clinical practice guidelines for Pulmonary Therapies Committee.
128. Chang AB, Bilton D Exacerbations in cystic fibrosis: 4-non-cystic fibrosis bronchiectasis. Thorax 2008, 63:269-276.
129. Graham V, Lasserson T, Rowe BH Antibiotics for acute asthma. Cochrane Database Syst Rev 2001, 3. CD002741.
130. Dickson RP, Erb-Downward JR, Prescott HC, et al. Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid. J Clin Microbiol 2014, 52:3605-3613.
131. Iwai S, Huang D, Fong S, et al. The lung microbiome of Ugandan HIV-infected pneumonia patients is compositionally and functionally distinct from that of San Franciscan patients. PLoS One 2014, 9:e95726.
132. Huang YJ, Sethi S, Murphy T, Nariya S, Boushey HA, Lynch SV Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease. J Clin Microbiol 2014, 52:2813-2823.
133. Millares L, Ferrari R, Gallego M, et al. Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis 2014, 33:1101-1111.
134. Stressmann FA, Rogers GB, Marsh P, et al. Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?. J Cyst Fibros 2011, 10:357-365.
135. Zhao J, Schloss PD, Kalikin LM, et al. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci USA 2012, 109:5809-5814.
136. Carmody LA, Zhao J, Schloss PD, et al. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. Ann Am Thorac Soc 2013, 10:179-187.
137. Price KE, Hampton TH, Gifford AH, et al. Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation. Microbiome 2013, 1:27.
138. Carmody LA, Zhao J, Kalikin LM, et al. The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation. Microbiome 2015, 3:12.
139. Tunney MM, Einarsson GG, Wei L, et al. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am J Respir Crit Care Med 2013, 187:1118-1126.
140. Hurley MN, Ariff AH, Bertenshaw C, Bhatt J, Smyth AR Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis. J Cyst Fibros 2012, 11:288-292.
141. Smith AL, Fiel SB, Mayer-Hamblett N, Ramsey B, Burns JL Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis. Chest 2003, 123:1495-1502.
142. Rogers GB, Zain NM, Bruce KD, et al. A novel microbiota stratification system predicts future exacerbations in bronchiectasis. Ann Am Thorac Soc 2014, 11:496-503.
143. Albert RK, Connett J, Bailey WC, et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med 2011, 365:689-698. the COPD Clinical Research Network.
144. Saiman L, Marshall BC, Mayer-Hamblett N, et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 2003, 290:1749-1756. the Macrolide Study Group.
145. Wong C, Jayaram L, Karalus N, et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet 2012, 380:660-667.
146. Molyneaux PL, Mallia P, Cox MJ, et al. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013, 188:1224-1231.
147. Labro MT, Abdelghaffar H Immunomodulation by macrolide antibiotics. J Chemother 2001, 13:3-8.
148. Herzig SJ, Howell MD, Ngo LH, Marcantonio ER Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA 2009, 301:2120-2128.
149. Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogué S, Ferrer M Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999, 354:1851-1858.
150. Siempos II, Ntaidou TK, Falagas ME Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med 2010, 38:954-962.
151. Pitsouni E, Alexiou V, Saridakis V, Peppas G, Falagas ME Does the use of probiotics/synbiotics prevent postoperative infections in patients undergoing abdominal surgery? A meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 2009, 65:561-570.
152. Khailova L, Frank DN, Dominguez JA, Wischmeyer PE Probiotic administration reduces mortality and improves intestinal epithelial homeostasis in experimental sepsis. Anesthesiology 2013, 119:166-177.
153. Abraham E It's all in the genes: moving toward precision medicine in critical illness. Crit Care Med 2013, 41:1363-1364.
154. Norris PR, Canter JA, Jenkins JM, Moore JH, Williams AE, Morris JA Personalized medicine: genetic variation and loss of physiologic complexity are associated with mortality in 644 trauma patients. Ann Surg 2009, 250:524-530.
155. Sen A, Yende S Towards personalized medicine in sepsis: quest for Shangri-La?. Crit Care 2013, 17:303.
156. Shaw AG, Sim K, Randell P, et al. Late-onset bloodstream infection and perturbed maturation of the gastrointestinal microbiota in premature infants. PLoS One 2015, 10:e0132923.
157. Mai V, Torrazza RM, Ukhanova M, et al. Distortions in development of intestinal microbiota associated with late onset sepsis in preterm infants. PLoS One 2013, 8:e52876.
158. Clarke TB Early innate immunity to bacterial infection in the lung is regulated systemically by the commensal microbiota via nod-like receptor ligands. Infect Immun 2014, 82:4596-4606.
159. Deshmukh HS, Liu Y, Menkiti OR, et al. The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice. Nat Med 2014, 20:524-530.
160. Azcarate-Peril MA, Foster DM, Cadenas MB, et al. Acute necrotizing enterocolitis of preterm piglets is characterized by dysbiosis of ileal mucosa-associated bacteria. Gut Microbes 2011, 2:234-243.
161. Sim K, Shaw AG, Randell P, et al. Dysbiosis anticipating necrotizing enterocolitis in very premature infants. Clin Infect Dis 2015, 60:389-397.
162. Bin-Nun A, Bromiker R, Wilschanski M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005, 147:192-196.
163. Lin HC, Hsu CH, Chen HL, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 2008, 122:693-700.
164. Prescott HC, Langa KM, Iwashyna TJ Readmission diagnoses after hospitalization for severe sepsis and other acute medical conditions. JAMA 2015, 313:1055-1057.